Pharmaceutical Subscribe to Pharmaceutical
Pharmaceutical Contract Development and Manufacturing Market (Pharmaceutical, Biologics, Active Pharma ingredients, tablet, Parenteral, Oral Liquid, Semi-Solids), End User (Big Pharma, Small Pharma, Generic Pharma, CRO) – Global Forecast to 2026
“Rising demand for generics and increasing investments in pharmaceutical R&D is driving the overall growth of the pharmaceutical contract development and manufacturing market”
The global pharmaceutical contract development and manufacturing...
Biosimilars Market by Product (Monoclonal antibodies (infliximab, rituximab, trastuzumab), Insulin, Interferon, Etanercept, Glucagon, Calcitonin), Indication (Oncology, Chronic Disease, Blood Disorder, Autoimmune Disease), Region – Global Forecast to 2026
“Increasing demand of biosimilars due to their cost-effectiveness and rising incidences of chronic disorders is driving the overall growth of the biosimilars market”
The global biosimilars market is projected to reach USD 44.7 billion by...
Italy – Healthcare, Regulatory and Reimbursement Landscape
Italy – Healthcare, Regulatory and Reimbursement Landscape
Summary
GlobalData, the industry analysis specialist, has released its latest report, “Italy – Healthcare, Regulatory and Reimbursement Landscape”. The report...
Pharmaceutical and Healthcare Sector Mergers, Acquisitions and Investment Trend Annual Review – 2020
Pharmaceutical and Healthcare Sector Mergers, Acquisitions and Investment Trend Annual Review – 2020
Summary
GlobalData’s “Pharmaceutical and Healthcare Sector Mergers, Acquisitions and Investment Trend Annual Review –...
Austria – Healthcare, Regulatory and Reimbursement Landscape
Austria – Healthcare, Regulatory and Reimbursement Landscape
Summary
GlobalData, the industry analysis specialist, has released its latest report, “Austria – Healthcare, Regulatory and Reimbursement Landscape”. The report...
Overactive Bladder – Epidemiology Forecast to 2030
Overactive Bladder – Epidemiology Forecast to 2030
Summary
Overactive bladder (OAB) syndrome is a group of urinary symptoms, defined as urinary urgency, usually with urinary frequency and nocturia, with or without urgency urinary incontinence...
Pharmaceuticals Industry Deals and Trends in May 2021 – Partnerships, Licensing, Investments, Mergers and Acquisitions (M&A)
Pharmaceuticals Industry Deals and Trends in May 2021 – Partnerships, Licensing, Investments, Mergers and Acquisitions (M&A)
Summary
GlobalData’s “Pharmaceuticals Industry Deals and Trends in May 2021 – Partnerships,...
Brazil – Healthcare, Regulatory and Reimbursement Landscape
Brazil – Healthcare, Regulatory and Reimbursement Landscape
Summary
GlobalData, the industry analysis specialist, has released its latest report, “Brazil – Healthcare, Regulatory and Reimbursement Landscape”. The report...
Pharmaceuticals Industry Deals and Trends in June 2021 – Partnerships, Licensing, Investments, Mergers and Acquisitions (M&A)
Pharmaceuticals Industry Deals and Trends in June 2021 – Partnerships, Licensing, Investments, Mergers and Acquisitions (M&A)
Summary
GlobalData’s “Pharmaceuticals Industry Deals and Trends in June 2021 – Partnerships,...
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer – September 15, 2021
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer – September 15, 2021
Summary
When faced with an outbreak of a pathogen with no known treatments, we are forced to rely on the pharmaceutical industry to develop interventions...
